
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.58 | 1.64 | 0.06 |
Shares | 98.01 | 98.01 | 0.00 |
Bonds | 0.01 | 0.01 | 0.00 |
Other | 0.40 | 0.40 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 21.06 | 18.84 |
Price to Book | 5.32 | 4.28 |
Price to Sales | 2.34 | 2.30 |
Price to Cash Flow | 18.61 | 15.61 |
Dividend Yield | 1.20 | 1.18 |
5 Years Earnings Growth | 11.16 | 11.02 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.87 | 99.59 |
Financial Services | 0.13 | 0.73 |
Number of long holdings: 144
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 11.22 | 764.88 | +0.33% | |
Boston Scientific | US1011371077 | 6.87 | 106.47 | +1.01% | |
Intuitive Surgical | US46120E6023 | 5.34 | 480.35 | -0.57% | |
AbbVie | US00287Y1091 | 5.13 | 197.07 | +0.95% | |
Abbott Labs | US0028241000 | 4.77 | 129.31 | +1.59% | |
UnitedHealth | US91324P1021 | 3.90 | 239.83 | +0.87% | |
Stryker | US8636671013 | 3.47 | 380.24 | +0.65% | |
Thermo Fisher Scientific | US8835561023 | 2.98 | 466.48 | +0.74% | |
Gilead | US3755581036 | 2.91 | 113.98 | +0.71% | |
Amgen | US0311621009 | 2.83 | 299.44 | +0.86% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
BlackRock S&P 500 Index K | 18.53B | 6.20 | 19.66 | 13.61 | ||
BlackRock International Index Instl | 11.86B | 20.59 | 16.16 | 6.62 | ||
BlackRock International Index Inv A | 11.86B | 20.42 | 15.88 | 6.35 | ||
BlackRock International Index K | 11.86B | 20.56 | 16.22 | 6.68 | ||
BlackRock Equity Dividend Instl | 10.01B | 10.39 | 12.77 | 10.26 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review